Gastroenterology, ISSN 0016-5085, 05/2019, Volume 156, Issue 6, pp. S-117 - S-117
Journal Article
Gastroenterology, ISSN 0016-5085, 05/2019, Volume 156, Issue 6, pp. S-507 - S-508
Journal Article
Human Pathology, ISSN 0046-8177, 11/2019
Journal Article
American Journal of Clinical Pathology, ISSN 0002-9173, 10/2019, Volume 152, Issue 5, pp. 563 - 569
Abstract Objectives To examine the immunohistochemical and ultrastructural features of hepatocellular cytoplasmic globules in venous outflow impairment (VOI)....
Venous outflow impairment | Liver | Globules | PATHOLOGY | Electron microscopy | LIVER-DISEASE | alpha-1 Antitrypsin
Venous outflow impairment | Liver | Globules | PATHOLOGY | Electron microscopy | LIVER-DISEASE | alpha-1 Antitrypsin
Journal Article
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, ISSN 1542-3565, 05/2019
Cytomegalovirus (CMV) can infect multiple areas of the gastrointestinal tract, most commonly the esophagus and colon. CMV esophagitis is the third leading...
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 08/2018, Volume 42, Issue 8, pp. 1083 - 1089
Journal Article
2019, ISBN 9783030155728, 564
eBook
Gastrointestinal Endoscopy, ISSN 0016-5107, 06/2018, Volume 87, Issue 6, p. AB294
Journal Article
Gastrointestinal Endoscopy, ISSN 0016-5107, 06/2018, Volume 87, Issue 6, pp. AB294 - AB294
Journal Article
Gastrointestinal Endoscopy, ISSN 0016-5107, 06/2019, Volume 89, Issue 6, pp. AB184 - AB185
Journal Article
Gastroenterology, ISSN 0016-5085, 04/2017, Volume 152, Issue 5, pp. S810 - S811
Journal Article
Gastroenterology, ISSN 0016-5085, 04/2017, Volume 152, Issue 5, pp. S2 - S3
Journal Article
Gastroenterology, ISSN 0016-5085, 2017, Volume 152, Issue 5, pp. S2 - S3
Journal Article
Gastroenterology, ISSN 0016-5085, 2017, Volume 152, Issue 5, pp. S810 - S811
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 06/2018, Volume 16, Issue 6, pp. 877 - 883.e1
Little is known about the features of immune-mediated non-celiac villous atrophies, such as autoimmune enteropathy (AIE). We investigated the demographic,...
Open-Capsule Budesonide | Refractory Diarrhea | Severe | Immune Enteropathy | Celiac disease | Medical research | Diarrhea | Medicine, Experimental | Adults | Comparative analysis | Gluten
Open-Capsule Budesonide | Refractory Diarrhea | Severe | Immune Enteropathy | Celiac disease | Medical research | Diarrhea | Medicine, Experimental | Adults | Comparative analysis | Gluten
Journal Article
16.
Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet
American Journal of Gastroenterology, ISSN 0002-9270, 06/2010, Volume 105, Issue 6, pp. 1412 - 1420
OBJECTIVES: Clinical response is typically observed in most adults with celiac disease (CD) after treatment with a gluten-free diet (GFD). The rate of mucosal...
ANTIBODIES | MALIGNANCY | MANAGEMENT | CLINICAL PRESENTATION | PREDICTORS | TERM-FOLLOW-UP | RISK | PREVALENCE | VILLOUS ATROPHY | GASTROENTEROLOGY & HEPATOLOGY | HISTOPATHOLOGY | Humans | Middle Aged | Male | Celiac Disease - mortality | Young Adult | Celiac Disease - pathology | Biopsy | Adolescent | Aged, 80 and over | Adult | Female | Aged | Celiac Disease - diet therapy | Cohort Studies | Diet, Gluten-Free | Intestinal Mucosa - pathology
ANTIBODIES | MALIGNANCY | MANAGEMENT | CLINICAL PRESENTATION | PREDICTORS | TERM-FOLLOW-UP | RISK | PREVALENCE | VILLOUS ATROPHY | GASTROENTEROLOGY & HEPATOLOGY | HISTOPATHOLOGY | Humans | Middle Aged | Male | Celiac Disease - mortality | Young Adult | Celiac Disease - pathology | Biopsy | Adolescent | Aged, 80 and over | Adult | Female | Aged | Celiac Disease - diet therapy | Cohort Studies | Diet, Gluten-Free | Intestinal Mucosa - pathology
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 05/2013, Volume 28, Issue 5, pp. 848 - 854
Background and Aim Hepatocellular carcinoma (HCC) is a major complication of cirrhosis and has been increasing in incidence in recent years. Fatty liver...
non‐cirrhotic hepatic steatosis | non‐alcoholic fatty liver disease | risk factor | hepatocellular carcinoma | intrahepatic cholangiocarcinoma | Hepatocellular carcinoma | Non-alcoholic fatty liver disease | Non-cirrhotic hepatic steatosis | Intrahepatic cholangiocarcinoma | Risk factor | UNITED-STATES | non-alcoholic fatty liver disease | ANTIDIABETIC THERAPY | non-cirrhotic hepatic steatosis | HEPATITIS-C-VIRUS | NATURAL-HISTORY | DIABETES-MELLITUS | HEPATOCELLULAR-CARCINOMA | RISK-FACTOR | STEATOSIS | STEATOHEPATITIS | GASTROENTEROLOGY & HEPATOLOGY | EPIDEMIOLOGY | Severity of Illness Index | Carcinoma, Hepatocellular - epidemiology | Liver - pathology | Prevalence | Fatty Liver - pathology | Humans | Middle Aged | Fatty Liver - complications | Male | Risk | Liver Neoplasms - etiology | Young Adult | Liver Neoplasms - epidemiology | Adolescent | Carcinoma, Hepatocellular - pathology | Non-alcoholic Fatty Liver Disease | Adult | Female | Liver Neoplasms - pathology | Aged | Carcinoma, Hepatocellular - etiology | Fatty Liver - epidemiology | Cohort Studies | Medicine, Experimental | Medical research | Fatty liver | Liver cirrhosis
non‐cirrhotic hepatic steatosis | non‐alcoholic fatty liver disease | risk factor | hepatocellular carcinoma | intrahepatic cholangiocarcinoma | Hepatocellular carcinoma | Non-alcoholic fatty liver disease | Non-cirrhotic hepatic steatosis | Intrahepatic cholangiocarcinoma | Risk factor | UNITED-STATES | non-alcoholic fatty liver disease | ANTIDIABETIC THERAPY | non-cirrhotic hepatic steatosis | HEPATITIS-C-VIRUS | NATURAL-HISTORY | DIABETES-MELLITUS | HEPATOCELLULAR-CARCINOMA | RISK-FACTOR | STEATOSIS | STEATOHEPATITIS | GASTROENTEROLOGY & HEPATOLOGY | EPIDEMIOLOGY | Severity of Illness Index | Carcinoma, Hepatocellular - epidemiology | Liver - pathology | Prevalence | Fatty Liver - pathology | Humans | Middle Aged | Fatty Liver - complications | Male | Risk | Liver Neoplasms - etiology | Young Adult | Liver Neoplasms - epidemiology | Adolescent | Carcinoma, Hepatocellular - pathology | Non-alcoholic Fatty Liver Disease | Adult | Female | Liver Neoplasms - pathology | Aged | Carcinoma, Hepatocellular - etiology | Fatty Liver - epidemiology | Cohort Studies | Medicine, Experimental | Medical research | Fatty liver | Liver cirrhosis
Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 150, Issue 4, pp. S307 - S308
Journal Article
Human Pathology, ISSN 0046-8177, 11/2019
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2015, Volume 21, Issue 11, pp. 2580 - 2590
Purpose: Esophageal cancer is an aggressive malignancy and often resistant to therapy. Overexpression of EGFR has been associated with poor prognosis of...
CELLS | PHASE-II TRIAL | ACTIVATION | GASTROESOPHAGEAL JUNCTION | ONCOLOGY | PATHWAY | ADENOCARCINOMA | EPIDERMAL-GROWTH-FACTOR | CANDIDATE ONCOGENE | FACTOR RECEPTOR | EXPRESSION | Porphyrins - administration & dosage | Transcriptional Activation - genetics | Prognosis | Humans | ErbB Receptors - genetics | Esophageal Neoplasms - pathology | Verteporfin | Gene Expression Regulation, Neoplastic - drug effects | ErbB Receptors - antagonists & inhibitors | Phosphoproteins - biosynthesis | Protein-Serine-Threonine Kinases - genetics | Epithelial Cells - pathology | Phosphoproteins - genetics | Protein-Serine-Threonine Kinases - biosynthesis | Drug Resistance, Neoplasm - genetics | Animals | Esophageal Neoplasms - genetics | ErbB Receptors - biosynthesis | Adaptor Proteins, Signal Transducing - genetics | Cell Line, Tumor | Adaptor Proteins, Signal Transducing - biosynthesis | Cell Proliferation - drug effects | Mice | Primary Cell Culture | Esophageal Neoplasms - drug therapy
CELLS | PHASE-II TRIAL | ACTIVATION | GASTROESOPHAGEAL JUNCTION | ONCOLOGY | PATHWAY | ADENOCARCINOMA | EPIDERMAL-GROWTH-FACTOR | CANDIDATE ONCOGENE | FACTOR RECEPTOR | EXPRESSION | Porphyrins - administration & dosage | Transcriptional Activation - genetics | Prognosis | Humans | ErbB Receptors - genetics | Esophageal Neoplasms - pathology | Verteporfin | Gene Expression Regulation, Neoplastic - drug effects | ErbB Receptors - antagonists & inhibitors | Phosphoproteins - biosynthesis | Protein-Serine-Threonine Kinases - genetics | Epithelial Cells - pathology | Phosphoproteins - genetics | Protein-Serine-Threonine Kinases - biosynthesis | Drug Resistance, Neoplasm - genetics | Animals | Esophageal Neoplasms - genetics | ErbB Receptors - biosynthesis | Adaptor Proteins, Signal Transducing - genetics | Cell Line, Tumor | Adaptor Proteins, Signal Transducing - biosynthesis | Cell Proliferation - drug effects | Mice | Primary Cell Culture | Esophageal Neoplasms - drug therapy
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.